To investigate whether CCL20 promoted cancer progression via remodeling TME, we established tumor-bearing Balb/c and C57BL/6N mouse models, which were orthotopically transplanted with pSIN-/CCL20-overexpressing 4T1 and Py8119 cells, respectively. Here, CCL20 is linked to neoplasm.